Discover insights from industry experts
Explore our library of insightful thought leadership and relevant healthcare industry topics
Featured Insights
E-Book
Ophthalmology Application Book, Volume 1
Explore how our team helps sponsors advance ocular therapeutics to address retinal disease, geographic atrophy, dry eye disease, progressive myopia and other vision-threatening conditions.
- Five high-impact case studies
- Practical solutions that maintain study momentum
- Thoughtful planning and responsive execution
- Deep therapeutic understanding to help sponsors navigate complexity
Search results will be updated while typing.
Article
The recruitment imperative: Why sites and patients determine cardiometabolic trial success
30 October 2026
Case Study
Coordinating Complex Obesity Studies Involving Energy Intake and Energy Expenditure Assessments
30 October 2026
Blog
Better medicines for children: Collaboration is the key to transforming pediatric drug development
29 October 2026
E-Book
Advancing Ocular Therapeutics: Real-World Lessons from Ophthalmology Clinical Development
27 October 2026
Blog
Executing rare disease trials successfully in China: Operational considerations for global sponsors
27 October 2026
Webinar
The Practical Reality of AI in Clinical Development: Governing AI for Trust, Impact and Operational Readiness
26 October 2026
Blog
AI must be framed as a force multiplier, not as a substitute
23 October 2026
Blog
Why global sponsors are increasingly including China early in multi-regional clinical trials
21 October 2026
Info Sheet
ADC Programs: Science, Safety and Operational Expertise
19 October 2026
Blog
Built to adapt: a dynamic delivery model that evolves with the sponsor
16 October 2026
Case Study
Site recruitment and engagement strategies to accelerate recruitment in a cardiovascular disease study
15 October 2026
Blog
How China's regulatory evolution is accelerating rare disease drug development
13 October 2026
Case Study
Leveraging digital health capabilities to retain patients in a perceived “low benefit” Phase IV study
9 October 2026
Blog
Beyond FSP vs Full-Service: Building the Right Operating Model for Accelerated Drug Development
8 October 2026
News
Accelerating the Path to First-in-Human Trials: FDA’s Expedited IND Pilot Program
7 October 2026
Blog
The rare disease opportunity in China: Large patient pools, faster identification and growing engagement
5 October 2026
Blog